114 related articles for article (PubMed ID: 12189216)
1. St. John's Wort: more implications for cancer patients.
Mansky PJ; Straus SE
J Natl Cancer Inst; 2002 Aug; 94(16):1187-8. PubMed ID: 12189216
[No Abstract] [Full Text] [Related]
2. Effects of St. John's wort on irinotecan metabolism.
Mathijssen RH; Verweij J; de Bruijn P; Loos WJ; Sparreboom A
J Natl Cancer Inst; 2002 Aug; 94(16):1247-9. PubMed ID: 12189228
[TBL] [Abstract][Full Text] [Related]
3. St John's Wort supplements endanger the success of organ transplantation.
Ernst E
Arch Surg; 2002 Mar; 137(3):316-9. PubMed ID: 11888457
[TBL] [Abstract][Full Text] [Related]
4. St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4.
Dürr D; Stieger B; Kullak-Ublick GA; Rentsch KM; Steinert HC; Meier PJ; Fattinger K
Clin Pharmacol Ther; 2000 Dec; 68(6):598-604. PubMed ID: 11180019
[TBL] [Abstract][Full Text] [Related]
5. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John's wort.
Bolley R; Zülke C; Kammerl M; Fischereder M; Krämer BK
Transplantation; 2002 Mar; 73(6):1009. PubMed ID: 11923712
[No Abstract] [Full Text] [Related]
7. St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole.
Wang LS; Zhou G; Zhu B; Wu J; Wang JG; Abd El-Aty AM; Li T; Liu J; Yang TL; Wang D; Zhong XY; Zhou HH
Clin Pharmacol Ther; 2004 Mar; 75(3):191-7. PubMed ID: 15001970
[TBL] [Abstract][Full Text] [Related]
8. St John's Wort: effect on CYP3A4 activity.
Roby CA; Anderson GD; Kantor E; Dryer DA; Burstein AH
Clin Pharmacol Ther; 2000 May; 67(5):451-7. PubMed ID: 10824623
[TBL] [Abstract][Full Text] [Related]
9. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme.
Markowitz JS; Donovan JL; DeVane CL; Taylor RM; Ruan Y; Wang JS; Chavin KD
JAMA; 2003 Sep; 290(11):1500-4. PubMed ID: 13129991
[TBL] [Abstract][Full Text] [Related]
10. [Phytotherapy threats with emphasis on St. John's wort medicines].
Sienkiewicz J; Czarnik-Matusewicz H; Wiela-Hojeńska A
Pol Merkur Lekarski; 2013 Nov; 35(209):309-12. PubMed ID: 24575655
[TBL] [Abstract][Full Text] [Related]
11. Modulation of irinotecan metabolism by ketoconazole.
Kehrer DF; Mathijssen RH; Verweij J; de Bruijn P; Sparreboom A
J Clin Oncol; 2002 Jul; 20(14):3122-9. PubMed ID: 12118026
[TBL] [Abstract][Full Text] [Related]
12. Effect of St John's wort on imatinib mesylate pharmacokinetics.
Frye RF; Fitzgerald SM; Lagattuta TF; Hruska MW; Egorin MJ
Clin Pharmacol Ther; 2004 Oct; 76(4):323-9. PubMed ID: 15470331
[TBL] [Abstract][Full Text] [Related]
13. Variability in St. John's wort formulations is an important consideration.
Kroll DJ; Shaw HS; Wall ME; Oberlies NH
Altern Ther Health Med; 2001; 7(6):21-2. PubMed ID: 11712467
[No Abstract] [Full Text] [Related]
14. Drug interactions with St John's wort : mechanisms and clinical implications.
Mannel M
Drug Saf; 2004; 27(11):773-97. PubMed ID: 15350151
[TBL] [Abstract][Full Text] [Related]
15. Additional discussions regarding the altered metabolism and transport of omeprazole after long-term use of St John's wort.
Xie HG
Clin Pharmacol Ther; 2005 Oct; 78(4):440-1. PubMed ID: 16198664
[No Abstract] [Full Text] [Related]
16. Influence of phenytoin on the disposition of irinotecan: a case report.
Murry DJ; Cherrick I; Salama V; Berg S; Bernstein M; Kuttesch N; Blaney SM
J Pediatr Hematol Oncol; 2002 Feb; 24(2):130-3. PubMed ID: 11990699
[TBL] [Abstract][Full Text] [Related]
17. [St.John's wort extract prescribed with foresight].
Hermann R
MMW Fortschr Med; 2013 Oct; 155(18):78-9. PubMed ID: 24288930
[No Abstract] [Full Text] [Related]
18. St. John's Wort: not so safe.
Chase SL
RN; 2000 Nov; 63(11):114. PubMed ID: 11147004
[No Abstract] [Full Text] [Related]
19. Drug interaction between St. John's wort and cyclosporine.
Barone GW; Gurley BJ; Ketel BL; Lightfoot ML; Abul-Ezz SR
Ann Pharmacother; 2000 Sep; 34(9):1013-6. PubMed ID: 10981246
[TBL] [Abstract][Full Text] [Related]
20. The influence of St John's Wort on CYP2C19 activity with respect to genotype.
Wang LS; Zhu B; Abd El-Aty AM; Zhou G; Li Z; Wu J; Chen GL; Liu J; Tang ZR; An W; Li Q; Wang D; Zhou HH
J Clin Pharmacol; 2004 Jun; 44(6):577-81. PubMed ID: 15145964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
